172 related articles for article (PubMed ID: 9854747)
21. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
22. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel.
Morone MA; Boden SD
Spine (Phila Pa 1976); 1998 Jan; 23(2):159-67. PubMed ID: 9474720
[TBL] [Abstract][Full Text] [Related]
23. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.
Koga A; Tokuhashi Y; Ohkawa A; Nishimura T; Takayama K; Ryu J
Spine (Phila Pa 1976); 2008 May; 33(12):1318-23. PubMed ID: 18496343
[TBL] [Abstract][Full Text] [Related]
24. Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model.
Bomback DA; Grauer JN; Lugo R; Troiano N; Patel TCh; Friedlaender GE
Spine (Phila Pa 1976); 2004 Aug; 29(15):1612-7. PubMed ID: 15284503
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
26. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model.
Tay BK; Le AX; Heilman M; Lotz J; Bradford DS
Spine (Phila Pa 1976); 1998 Nov; 23(21):2276-81. PubMed ID: 9820906
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for spine fusion.
Khan SN; Hidaka C; Sandhu HS; Girardi FP; Cammisa FP; Diwan AD
Orthop Clin North Am; 2000 Jul; 31(3):473-84. PubMed ID: 10882472
[TBL] [Abstract][Full Text] [Related]
28. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
29. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
30. Efficient bone formation by gene transfer of human LIM mineralization protein-3.
Pola E; Gao W; Zhou Y; Pola R; Lattanzi W; Sfeir C; Gambotto A; Robbins PD
Gene Ther; 2004 Apr; 11(8):683-93. PubMed ID: 14724674
[TBL] [Abstract][Full Text] [Related]
31. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
32. Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion.
Louis-Ugbo J; Murakami H; Kim HS; Minamide A; Boden SD
Spine (Phila Pa 1976); 2004 Feb; 29(4):360-6; discussion Z1. PubMed ID: 15094531
[TBL] [Abstract][Full Text] [Related]
33. [Effects of recombinant gene lentivirus containing LIM mineralization protein-1 on proliferation effect and expression of bone marrow mesenchymal stem cells in rats].
Liang CS; Xiang C; Wei ZY; Hou HM; Qin YZ; Wei XC
Zhongguo Gu Shang; 2013 Dec; 26(12):1023-7. PubMed ID: 24654519
[TBL] [Abstract][Full Text] [Related]
34. Overexpressed LIM mineralization proteins do not require LIM domains to induce bone.
Liu Y; Hair GA; Boden SD; Viggeswarapu M; Titus L
J Bone Miner Res; 2002 Mar; 17(3):406-14. PubMed ID: 11874232
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of coralline hydroxyapatite and direct current electrical stimulation in lumbar spinal fusion.
Bozic KJ; Glazer PA; Zurakowski D; Simon BJ; Lipson SJ; Hayes WC
Spine (Phila Pa 1976); 1999 Oct; 24(20):2127-33. PubMed ID: 10543011
[TBL] [Abstract][Full Text] [Related]
36. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study.
Boden SD; Grob D; Damien C
Spine (Phila Pa 1976); 2004 Mar; 29(5):504-14. PubMed ID: 15129063
[TBL] [Abstract][Full Text] [Related]
37. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo.
Yoon ST; Park JS; Kim KS; Li J; Attallah-Wasif ES; Hutton WC; Boden SD
Spine (Phila Pa 1976); 2004 Dec; 29(23):2603-11. PubMed ID: 15564908
[TBL] [Abstract][Full Text] [Related]
38. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation.
Boden SD; Liu Y; Hair GA; Helms JA; Hu D; Racine M; Nanes MS; Titus L
Endocrinology; 1998 Dec; 139(12):5125-34. PubMed ID: 9832452
[TBL] [Abstract][Full Text] [Related]
39. Spine fusion by gene therapy.
Yoon ST; Boden SD
Gene Ther; 2004 Feb; 11(4):360-7. PubMed ID: 14724678
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.
Wheeler DL; Lane JM; Seim HB; Puttlitz CM; Itescu S; Turner AS
Spine J; 2014 Mar; 14(3):435-44. PubMed ID: 24438940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
